Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Kohjin Bio

コージンバイオ

177A · TSE · Chemicals · 2 articles

Financials Consolidated

Revenue¥4.94bn−5.1% year on yearConsolidated · FY3/26

Ordinary profit¥341m−68.0% year on yearConsolidated · FY3/26

Net profit¥251m−68.4% year on yearConsolidated · FY3/26

Dividend per share¥10.00FY3/26

Performance over time

Revenue
¥3.95bnFY3/22
¥4.74bnFY3/23
¥4.77bnFY3/24
¥5.21bnFY3/25
¥4.94bnFY3/26
Ordinary profit
¥918mFY3/22
¥1.24bnFY3/23
¥636mFY3/24
¥1.07bnFY3/25
¥341mFY3/26
Net profit (attributable)
¥588mFY3/22
¥830mFY3/23
¥385mFY3/24
¥795mFY3/25
¥251mFY3/26
Op. cash flow
¥763mFY3/22
¥461mFY3/23
¥824mFY3/24
¥916mFY3/25
¥699mFY3/26

People & pay

Employees, whole group176 peopleFY3/26

Employees, parent company (non-consolidated)150 peopleFY3/26

Average salary¥5.54mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥4.94bn−5.1% year on year¥341m¥251m¥49.11¥10.00¥8.90bn¥5.95bn¥699m
FY3/25¥5.21bn+9.1% year on year¥1,065m¥795m¥157.57¥24.00¥9.07bn¥5.78bn¥916m
FY3/24¥4.77bn+0.6% year on year¥636m¥385m¥92.43¥14.00¥6.59bn¥3.34bn¥824m
FY3/23¥4.74bn+20.2% year on year¥1,244m¥830m¥199.23¥19.00¥6.13bn¥3.02bn¥461m
FY3/22¥3.95bn¥918m¥588m¥173.50¥100.00¥5.60bn¥2.22bn¥763m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YB5D · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:177A

Tokyo Brief coverage

  1. Kohjin Bio splits chair and president roles, adopts audit-committee structure

    The move: Kohjin Bio’s shareholders approved an audit and supervisory committee structure, split the top jobs between a chair and president, and signed off on a ¥10 per share dividend worth ¥51.1mn. Separately, Takahito Nakamura remained disclosed as the controlling shareholder with 53.91% of voting rights.

  2. Kohjin Bio adopts dual representative setup after AGM vote

    The move: Kohjin Bio adopted an audit-and-supervisory-committee model and split the top representative role between Takahito Nakamura as chairman and Yuichi Nakamura as president, while a same-day disclosure showed Takahito still controlled 53.91% of voting rights.

All articles loaded · 2 shown

AGM votes

This season’s shareholder voting results.

1 meeting · data through

AGM votes
ProposalApprovalResultFiling
Appropriation of surplus
Original (Japanese)剰余金処分の件
99.28%Votes cast: 99.43%ApprovedFiled  — filing S100YM6I
Amendment of articles
Original (Japanese)定款一部変更の件
99.63%Votes cast: 99.78%ApprovedFiled  — filing S100YM6I
Election of 4 directors
Original (Japanese)取締役4名選任の件
· 中村 孝人
99.02%Votes cast: 99.17%ApprovedFiled  — filing S100YM6I
Election of 4 directors
Original (Japanese)取締役4名選任の件
· 中村 雄一
99.06%Votes cast: 99.21%ApprovedFiled  — filing S100YM6I
Election of 4 directors
Original (Japanese)取締役4名選任の件
· 對比地 久義
99.05%Votes cast: 99.20%ApprovedFiled  — filing S100YM6I
Show 7 more meetings (12 total)
AGM votes
ProposalApprovalResultFiling
Election of 4 directors
Original (Japanese)取締役4名選任の件
· 原 稔
99.25%Votes cast: 99.40%ApprovedFiled  — filing S100YM6I
Election of 3 audit committee directors
Original (Japanese)監査等委員である取締役3名選任の件
· 森兼 康博
99.31%Votes cast: 99.45%ApprovedFiled  — filing S100YM6I
Election of 3 audit committee directors
Original (Japanese)監査等委員である取締役3名選任の件
· 廣澤 一弘
99.35%Votes cast: 99.50%ApprovedFiled  — filing S100YM6I
Election of 3 audit committee directors
Original (Japanese)監査等委員である取締役3名選任の件
· 梅津 英明
99.36%Votes cast: 99.51%ApprovedFiled  — filing S100YM6I
Matter of appointment of the accounting auditorMachine translated
Original (Japanese)会計監査人選任の件
· RSM清和監査法人
99.63%Votes cast: 99.78%ApprovedFiled  — filing S100YM6I
Matter regarding determination of remuneration for directors (excluding directors who are audit and supervisory committee members)Machine translated
Original (Japanese)取締役(監査等委員である取締役を除く。)報酬決定の件
99.46%Votes cast: 99.60%ApprovedFiled  — filing S100YM6I
Matter regarding determination of remuneration for directors who are audit and supervisory committee membersMachine translated
Original (Japanese)監査等委員である取締役の報酬決定の件
99.52%Votes cast: 99.66%ApprovedFiled  — filing S100YM6I

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

3 fiscal years · data through

Balance-sheet value
¥6.12mFY3/24
¥6.80mFY3/25
¥7.57mFY3/26

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 20261¥7.57m0.13%——Filed  — filing S100YB5D
31 Mar 20251¥6.8m0.12%——Filed  — filing S100W2HI
31 Mar 20241¥6.12m0.18%——Filed  — filing S100TX40